Cancer Risk Elevated With Glyburide Over Other Sulfonylureas Cancer Risk Elevated With Glyburide Over Other Sulfonylureas
Overall cancer risk with glyburide was not significantly elevated, but significant dose- and duration-response relationships were seen with glyburide and breast, prostate, and colorectal cancers. Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
More News: Cancer | Cancer & Oncology | Colorectal Cancer | Diabetes | Endocrinology | Glyburide | Health